SA
ALNY logo
Alnylam Pharmaceuticals, Inc.(ALNY)
Closing price · checked 8:16 PM ETAbout this dataData status
$143.82▼-4.00 (-2.71%)
Extended:$144.50+0.68 (+0.47%)· 8:16 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Alnylam Pharmaceuticals, Inc. (ALNY)

R&D to Revenue

35.66%

Fiscal year · Period ending:

ALNY logo

ALNY R&D to Revenue

Latest reported35.66%
ALNY FY R&D/Revenue (0.00% → 35.66%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

ALNY r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Alnylam Pharmaceuticals, Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to RevenueChange
35.6624%−14.43 pts
50.0939%−4.84 pts
54.9373%−30.18 pts
85.1166%−8.71 pts
93.8254%−39.04 pts
132.8629%−165.25 pts
298.1179%−376.60 pts
674.721%+240.26 pts
434.4637%−376.39 pts
810.8569%+138.07 pts
672.7863%+296.51 pts
376.2762%+136.79 pts
239.4831%+109.74 pts
129.74%+9.76 pts
119.9838%+13.64 pts
106.3404%−1.81 pts
108.1535%+7.40 pts
100.7487%−136.37 pts
237.1181%+52.20 pts
184.9165%−432.98 pts
617.8971%+42.79 pts
575.1052%−6,866.37 pts
7,441.4773%+7,441.48 pts
0%—

Frequently asked questions: ALNY r&d to revenue

What is Alnylam Pharmaceuticals, Inc. (ALNY)'s current r&d to revenue?

Alnylam Pharmaceuticals, Inc. (ALNY)'s latest reported r&d to revenue (Fiscal year) is 35.66% as of Dec 31, 2025. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for ALNY?

Stock Alarm Pro provides 24 dated annual fiscal periods observations for Alnylam Pharmaceuticals, Inc. (ALNY)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ALNY's r&d to revenue to peers or set an alert?

You can open ALNY's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ALNY delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.